In a significant development, AstraZeneca has made a pivotal admission regarding its COVID-19 vaccine in court documents, conceding for the first time that it can lead to a rare side effect. This admission comes amidst mounting legal pressure and a class action lawsuit alleging serious injury and death resulting from the vaccine. The pharmaceutical giant, … Read more
As the year approaches, the Department of Health (DOH) has issued a warning that the new subvariant of COVID-19, known as JN.1, is now present in the country and is classified as a “variant of interest.” In the DOH report on Sunday, December 24, there are 18 cases of JN.1 nationwide, with the earliest case … Read more
In a statement from Dr. Rontgene Solante, the president of the Philippine College of Physicians (PCP), the new COVID-19 subvariant JN.1, currently circulating in the United States and other countries, is expected to enter the Philippines in “due time.” He emphasized the need to closely monitor this new subvariant, which could potentially lead to an … Read more